Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals
Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides
177
Lu (ZHER2-HSA-chelator-
177
Lu) or
212
Pb (ZHER2-HSA-chelator-
212
Pb). The objective was to evaluate
in vitro
the cytotoxic activity of the targeted radiopha...
Alternative Titles
Full title
Specific Cytotoxicity of Targeted 177Lu and 212Pb-Based Radiopharmaceuticals
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2580693628
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2580693628
Other Identifiers
ISSN
0007-4888
E-ISSN
1573-8221
DOI
10.1007/s10517-021-05283-4